Skip to main content

The independent medical news service

18-09-2021 | Oncology | News | Article

Trastuzumab deruxtecan shows ‘unprecedented efficacy’ in DESTINY-Breast03

Previously treated patients with HER2-positive metastatic breast cancer derive a significant progression-free survival benefit from trastuzumab deruxtecan relative to trastuzumab emtansine, find the DESTINY-Breast03 investigators.

17-09-2021 | Oncology | News | Article

BrighTNess update confirms benefit of adding carboplatin to neoadjuvant chemo in TNBC

Adding carboplatin to neoadjuvant paclitaxel is sufficient to boost the outcomes of patients with triple-negative breast cancer, with no further improvement from the addition of veliparib to the dual regimen, confirms a follow-up analysis of the BrighTNess trial.

16-09-2021 | Oncology | News | Article

Residual cancer burden may predict treatment efficacy in breast cancer

Residual cancer burden offers prognostic information after neoadjuvant chemotherapy across breast cancer subtypes and treatments, show data from I-SPY2.

10-09-2021 | Oncology | News | Article

Surgery extent impacts long-term QoL in young breast cancer survivors

Young women who undergo mastectomy for breast cancer report poorer quality of life than those treated with breast conserving therapy more than 5 years after surgery, particularly when they also receive radiotherapy, research shows.

06-09-2021 | Oncology | News | Article

Significant declines in cancer diagnoses during first year of COVID-19 pandemic

The number of new cancer diagnoses during the first year of the COVID-19 pandemic was lower than in the prepandemic period, report US researchers.

03-09-2021 | Oncology | News | Article

Cardioprotection worthwhile in anthracycline-treated breast cancer

Cardioprotective pharmacologic therapy may be effective against anthracycline-related subclinical heart damage in women with nonmetastatic breast cancer, with bisoprolol potentially offering greater benefits than ramipril, interim SAFE study data suggest.